Overview
David Feiglin is a Nuclear Medicine provider practicing medicine in Syracuse, New York.
Dr. Feiglin is highly rated in 1 condition, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, ALK-Positive Non-Small Cell Lung Cancer, Classical Hodgkin Lymphoma, and Lung Nodules.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
750 E Adams St, Syracuse, NY 13210
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Upstate Medical University
Mary Mcgrath is a Nuclear Medicine provider practicing medicine in Syracuse, New York. Dr. Mcgrath is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Muscle Invasive Bladder Cancer, Melorheostosis with Osteopoikilosis, Melorheostosis, and Osteopenia.
Frequently Asked Questions about Dr. David H. Feiglin
How do I make an appointment with Dr. David H. Feiglin?
You can book an appointment with Dr. David H. Feiglin by calling their office at 315-464-6672. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. David H. Feiglin a top-rated expert for Muscle Invasive Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. David H. Feiglin is classified as an Advanced expert for Muscle Invasive Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. David H. Feiglin specialize in?
While Dr. David H. Feiglin is a Nuclear Medicine, they have specific expertise in Muscle Invasive Bladder Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Classical Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nuclear Medicine.
Does Dr. David H. Feiglin participate in research or clinical trials?
Yes. Dr. David H. Feiglin has published 9 articles and abstracts on conditions like Muscle Invasive Bladder Cancer. You can view a list of Dr. David H. Feiglin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Muscle Invasive Bladder CancerDr. Feiglin isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Feiglin isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Classical Hodgkin LymphomaDr. Feiglin isExperienced. Learn about Classical Hodgkin Lymphoma.
- Lung NodulesDr. Feiglin isExperienced. Learn about Lung Nodules.
- Marginal Zone Lymphoma (MZL)Dr. Feiglin isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Non-Muscle Invasive Bladder CancerDr. Feiglin isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.